Insmed Inc. (INSM)
Insmed Inc. reported revenue of $606.42M for the fiscal year ended Dec 31, 2025, up 66.7% from $363.71M the year before. Net income was a loss of $1.28B, a net margin of -210.5% (prior year: −$913.77M). At the end of that fiscal year the company reported total assets of $2.26B and shareholders' equity of $738.98M.
Revenue
$606.42M
+66.7% vs prior year
Net income
−$1.28B
Net margin -210.5%
Diluted EPS
−$6.42
USD per share
Total assets
$2.26B
At Dec 31, 2025
Equity
$738.98M
At Dec 31, 2025
Shares outstanding
219M
As of Oct 23, 2026
Explore Insmed Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 29, 2026
- 10-QFiled Aug 6, 2026
- 10-QFiled May 7, 2026
- 10-KFiled Feb 19, 2026
- 10-QFiled Oct 30, 2025
- 10-QFiled Aug 7, 2025
Source: SEC EDGAR XBRL company facts for CIK 1104506 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.